Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kestra Medical Technologies (KMTS) Depreciation & Amortization (CF) (2024 - 2025)

Historic Depreciation & Amortization (CF) for Kestra Medical Technologies (KMTS) over the last 2 years, with Q4 2025 value amounting to $2.4 million.

  • Kestra Medical Technologies' Depreciation & Amortization (CF) rose 2696.63% to $2.4 million in Q4 2025 from the same period last year, while for Oct 2025 it was $8.1 million, marking a year-over-year decrease of 2686.11%. This contributed to the annual value of $8.0 million for FY2025, which is 3107.27% down from last year.
  • As of Q4 2025, Kestra Medical Technologies' Depreciation & Amortization (CF) stood at $2.4 million, which was up 2696.63% from $2.0 million recorded in Q3 2025.
  • Kestra Medical Technologies' 5-year Depreciation & Amortization (CF) high stood at $3.5 million for Q2 2024, and its period low was $1.8 million during Q2 2025.